[68Ga]Ga-DOTA-HBED-bisphosphonate

N/A

Report date: 2025/11/27 17:57:14
NME

Base Information

Drug Name[68Ga]Ga-DOTA-HBED-bisphosphonate
Drug Alias Name[68Ga]Ga-DOTA-HBED-CC-bisphosphonate[68Ga]Ga-P15-041Ga-P15-041[68Ga]HBED-CC-BP
ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionEmission-computed tomography enhancersPositron-emission tomography enhancers
TargetsUpdating
Therapy Area/IndicationsBone metastases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesFive Eleven Pharma IncUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesFive Eleven Pharma IncUniversity Of Pennsylvania
Inactive CompaniesN/A
Active IndicationsBone metastases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A